Announced Tue, 14 Jul · 14:50 IST
Oxygenta Pharma files quarterly demat compliance certificate for June 2026 quarter
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.4%1-day move
₹49.00
prior close
—
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+0.4+3.6-1.8+2.0-1.2+0.3————
Up moveDown movePending
AI summary
Oxygenta Pharmaceutical submitted its quarterly compliance certificate under SEBI Regulation 74(5) for the quarter ended 30 June 2026. The company’s Registrar, Venture Capital and Corporate Investments, confirmed that all dematerialised securities received were properly cancelled after verification and that records at NSDL and CDSL were updated as registered owner within the required 15 day timeline. The certificate has been filed with BSE (Scrip Code 524636).
Likely market impact
Routine regulatory compliance filing with no material impact on the stock or shareholders.